human | Q5 |
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q28258975 | A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus |
Q34694711 | A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. |
Q24629130 | A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus |
Q36851638 | A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. |
Q37450136 | Abdominal obesity, gender and the risk of rheumatoid arthritis - a nested case-control study |
Q35620298 | Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis |
Q36475075 | Association analysis of copy numbers of FC-gamma receptor genes for rheumatoid arthritis and other immune-mediated phenotypes |
Q35092932 | Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis |
Q28254474 | Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus |
Q28265206 | Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX |
Q35626851 | Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis |
Q34153114 | Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness |
Q35620360 | Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden |
Q35617716 | Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study |
Q33859039 | Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case-control study |
Q36513993 | Co-morbidity in patients with early rheumatoid arthritis - inflammation matters |
Q37240538 | Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis |
Q28290376 | Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor-8 gene variants |
Q35620317 | Diagnostic properties of metabolic perturbations in rheumatoid arthritis |
Q40131399 | Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts |
Q39043111 | EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis |
Q39875697 | Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis |
Q37102098 | Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations |
Q41583910 | Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis |
Q29417000 | Genetics of rheumatoid arthritis contributes to biology and drug discovery |
Q30419111 | High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis |
Q36307076 | Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study |
Q36172927 | Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis? |
Q24816519 | Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. |
Q35094654 | Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment |
Q36166090 | Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis |
Q35128863 | Novel information on the non-neuronal cholinergic system in orthopedics provides new possible treatment strategies for inflammatory and degenerative diseases |
Q34896568 | PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease |
Q24530690 | Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus |
Q40850003 | Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis |
Q36565997 | Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis |
Q35876782 | Selective IgA deficiency in autoimmune diseases |
Q35990362 | Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis |
Q33749195 | Ten years with biologics: to whom do data on effectiveness and safety apply? |
Q36392280 | The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden |
Q33892790 | The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study |
Q36013844 | Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists |
Q37443729 | What happens before the onset of rheumatoid arthritis? |
Q30278872 | Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases |
Search more.